Results 61 to 70 of about 1,135 (79)

[Applications and prospects of graphene and its derivatives in bone repair]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Du Z, Ma Y, Wang C, Zhang R, Li X.
europepmc   +1 more source

[Application of <i>flavonoid</i> in disease treatment based on multi-omics technologies]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Zhang W, Han K, Zhao K, Yang C, Jin M, Wang Y, Jiang Z.   +6 more
europepmc   +1 more source

[Chinese expert consensus on the diagnosis and treatment of high-altitude polycythemia(2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Red Blood Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association, Chinese Hospital Association Hematology Branch.   +3 more
europepmc   +1 more source

[Occurrence status and treatment strategies of abnormal growth and development in children with methylmalonic acidemia]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Wei HY, Li DX.
europepmc   +1 more source

[Clinical efficacy and safety of rituximab in treating renal injury in primary Sjögren syndrome]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Zhao Y, Ni M, Li X, Wang B, Cheng G, He J, Jin Y.   +6 more
europepmc   +1 more source

[Defect modification of calcium silicate and its application in oral bacteriostasis and tooth remineralization]. [PDF]

Hua Xi Kou Qiang Yi Xue Za Zhi
Hu Y, Zhang S, Zhang J, Luo H, Li Y, Zhang J, Chen X.   +6 more
europepmc   +1 more source

[Analysis of nutritional status before and after different induction therapies in children with Crohn's disease]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Chen LL, Yu Y, Luo YY, Chen J.
europepmc   +1 more source

[Biocompatibility of 3D printed biodegradable WE43 magnesium alloy scaffolds and treatment of bone defects]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Min S, Tian Y.
europepmc   +1 more source

[Research progress on poor response, resistance mechanisms, and influencing factors of immunotherapy for hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Huang M, Zhang FN, Gong H, Liu CC, Zhao TT, He N.   +5 more
europepmc   +1 more source